Skip to main content
MITI
OTC Technology

Mitesco Reports Q1 Loss, Near-Zero Cash, Going Concern Warning Amidst Heavy Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.05
Mkt Cap
$1.039M
52W Low
$0.041
52W High
$0.45
52W Position info
21% above low
Off High info
89% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MITI sits 21% above its 52-week low of $0.041.

Summary

Mitesco's Q1 2026 report reveals a critical financial state with minimal cash, no revenue, and ongoing reliance on highly dilutive debt and equity to address mounting liabilities and a going concern warning.


Key Events · Legal and Risk Events · MITI

  • Severe Liquidity Crisis

    Cash and cash equivalents plummeted to $1,533 as of March 31, 2026, down from $100,857 at year-end 2025, indicating an imminent liquidity crisis.

  • Going Concern Warning

    Management explicitly stated substantial doubt about the company's ability to continue as a going concern for the next year, dependent on raising capital and generating revenue.

  • No Revenue & Increased Losses

    The company reported $0 revenue for Q1 2026 (down from $17,000 in Q1 2025) and a net loss of $(777,289), highlighting a complete halt in revenue-generating operations.

  • Massive Dilution Continues

    Shares outstanding increased by approximately 38.7% from 15,093,055 at December 31, 2025, to 20,940,597 as of May 20, 2026, driven by conversions of preferred stock, dividends, and new dilutive bridge financing.


Analysis · MITI · Technology

Mitesco, a micro-cap company, reported a significant net loss and near-zero cash reserves for Q1 2026, raising substantial doubt about its ability to continue operations. The company continues to rely on highly dilutive financing and share issuances to manage its substantial liabilities and legal settlements, leading to a nearly 40% increase in shares outstanding since year-end. Material weaknesses in internal controls persist, compounding the financial instability.

At the time of this filing, MITI was trading at $0.05 on OTC in the Technology sector, with a market capitalization of approximately $1M. The 52-week trading range was $0.04 to $0.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Aug 04, 2026, 7:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.035
Real-time Price: $0.030 info
Change: -$0.0050 (-14%) info
Market Cap: $628.218K info
MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.030 info
Change: -$0.0675 (-69%) info
Market Cap: $628.218K info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.030 info
Change: -$0.040 (-57%) info
Market Cap: $628.218K info
MITI
Jul 02, 2026, 7:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.075468
Real-time Price: $0.030 info
Change: -$0.045468 (-60%) info
Market Cap: $628.218K info
MITI
Jun 30, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.073
Real-time Price: $0.030 info
Change: -$0.043 (-59%) info
Market Cap: $628.218K info